Nuveen’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.3M | Sell |
64,675
-23,862
| -27% | -$11M | 0.01% | 927 |
|
|
2026
Q1 | $42.5M | Buy |
88,537
+1,735
| +2% | +$888K | 0.01% | 724 |
|
|
2025
Q4 | $48.8M | Buy |
86,802
+27,475
| +46% | +$15.6M | 0.01% | 654 |
|
|
2025
Q3 | $30.5M | Buy |
59,327
+9,360
| +19% | +$4.09M | 0.01% | 879 |
|
|
2025
Q2 | $15.7M | Sell |
49,967
-12,047
| -19% | -$3.62M | ﹤0.01% | 1243 |
|
|
2025
Q1 | $18.9M | Sell |
62,014
-3,816
| -6% | -$1.28M | 0.01% | 1158 |
|
|
2024
Q4 | $21.9M | Sell |
65,830
-2,044
| -3% | -$693K | 0.01% | 1137 |
|
|
2024
Q3 | $22.7M | Sell |
67,874
-18,369
| -21% | -$6.98M | 0.01% | 1097 |
|
|
2024
Q2 | $35.5M | Sell |
86,243
-14,941
| -15% | -$5.92M | 0.01% | 799 |
|
|
2024
Q1 | $40.9M | Buy |
101,184
+735
| +0.7% | +$258K | 0.01% | 730 |
|
|
2023
Q4 | $30.8M | Buy |
100,449
+4,676
| +5% | +$1.26M | 0.01% | 879 |
|
|
2023
Q3 | $23.2M | Buy |
95,773
+18,201
| +23% | +$4.66M | 0.01% | 960 |
|
|
2023
Q2 | $18.6M | Sell |
77,572
-51,651
| -40% | -$10.7M | 0.01% | 1114 |
|
|
2023
Q1 | $24.3M | Buy |
129,223
+34,326
| +36% | +$7.1M | 0.01% | 908 |
|
|
2022
Q4 | $20.2M | Buy |
94,897
+7,280
| +8% | +$1.45M | 0.01% | 1038 |
|
|
2022
Q3 | $13.8M | Sell |
87,617
-5,071
| -5% | -$809K | 0.01% | 1272 |
|
|
2022
Q2 | $13.9M | Sell |
92,688
-38,159
| -29% | -$5.52M | 0.01% | 1304 |
|
|
2022
Q1 | $21.5M | Sell |
130,847
-12,533
| -9% | -$2.07M | 0.01% | 1162 |
|
|
2021
Q4 | $29.3M | Buy |
143,380
+880
| +0.6% | +$184K | 0.01% | 998 |
|
|
2021
Q3 | $26.5M | Sell |
142,500
-24,772
| -15% | -$4.52M | 0.01% | 1075 |
|
|
2021
Q2 | $29.5M | Sell |
167,272
-22,652
| -12% | -$3.91M | 0.01% | 1083 |
|
|
2021
Q1 | $31.2M | Buy |
189,924
+33,344
| +21% | +$5.1M | 0.01% | 1009 |
|
|
2020
Q4 | $21.8M | Buy |
156,580
+66
| +0% | +$8.32K | 0.01% | 1204 |
|
|
2020
Q3 | $17.5M | Sell |
156,514
-4,638
| -3% | -$536K | 0.01% | 1138 |
|
|
2020
Q2 | $15M | Sell |
161,152
-4,443
| -3% | -$378K | 0.01% | 1224 |
|
|
2020
Q1 | $12.2M | Buy |
165,595
+1,064
| +0.6% | +$92.4K | 0.01% | 1178 |
|
|
2019
Q4 | $13.8M | Sell |
164,531
-239,479
| -59% | -$18.5M | 0.01% | 1394 |
|
|
2019
Q3 | $34M | Buy |
404,010
+300,604
| +291% | +$22.7M | 0.01% | 856 |
|
|
2019
Q2 | $6.76M | Buy |
103,406
+80,225
| +346% | +$4.62M | ﹤0.01% | 1827 |
|
|
2019
Q1 | $1.37M | Buy |
23,181
+1,802
| +8% | +$108K | 0.01% | 694 |
|
|
2018
Q4 | $1.13M | Buy |
+21,379
| New | +$1.17M | 0.01% | 698 |
|
Other funds holding MEDP
WA
Nuveen's MEDP Position: Q2 2026 in Review
Nuveen reduced its Medpace (MEDP) stake by 27% in Q2 2026, selling an estimated $11M and leaving 64,675 shares worth $34.3M. The position accounts for 0.01% of the portfolio, ranked #927.
Nuveen first reported a position in MEDP in Q4 2018 and has held it in 31 quarters since. The position peaked at $48.8M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Nuveen held 64,675 shares of Medpace worth $34.3M as of Q2 2026.
- Nuveen sold 23,862 Medpace shares in Q2 2026, an estimated $11M.
- Medpace made up 0.01% of Nuveen's portfolio in Q2 2026, its #927 holding.
- Nuveen first reported a position in Medpace in Q4 2018 and has held it in 31 quarters since.
- Nuveen's Medpace position peaked at $48.8M in Q4 2025.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.